Archives
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
Vol 20. no 4. December 2015
Main subject: Biological Remedies in Allergology
Chief Editor: prof. dr hab. med. Marek Niedoszytko
Biological Remedies in Allergology (p. 214)
Marek Niedoszytko, Ewa Jassem
The qualification of severe asthma patients to the treatment with use of omalizumab – the guide for doctors (p. 215-217)
Iwona Damps-Konstańska
Omalizumab in the treatment of urticaria (p. 218-222)
Joanna Dawicka, Aleksandra Wilkowska, Roman Nowicki
The use of omalizumab beyond asthma and urticaria (p. 223-230)
Karol Kempiński, Marek Niedoszytko
Application of m-TOR inhibitors in the selected dermatologic lesions (p. 231-235)
Beata Imko-Walczuk
Hot topic
New opportunities for the treatment of acute attacks of hereditary angioedema (p. 236-238)
Grzegorz Porębski
Tiotropium – new agent in asthma therapy (p. 239-241)
Maciej Kupczyk
Review articles
Rhinitis – important phenotypes, endotypes and therapy (p. 242-252)
Rafał Fornal, Ryszard Kurzawa, Łukasz Błażowski, Iwona Sak
Original articles
Asthma exacerbations after discontinuation of omalizumab treatment (p. 253-256)
Wojciech Budny, Roman Skiepko, Mateusz Łukaszyk, Maciej Klimek, Ziemowit Ziętkowski, Anna Bodzenta-Łukaszyk
Familiarity with the clinical picture and treatment methods of hymenoptera venom allergy (HVA) by Polish general practitioners (GPs) (p. 257-263)
Gabriela Staroń, Paulina Hościło, Marita Nittner-Marszalska, Anna Hans-Wytrychowska, Anna Wolańczyk-Mędrala
Parainfluenza type 3 (PIV-3) infection of primary bronchial epithelial cells grown in vitro as an experimental model of bronchial asthma exacerbations (p. 264-268)
Sylwia Moskwa, Wojciech Piotrowski, Jerzy Marczak, Anna Lewandowska-Polak, Marzanna Jarzębska, Małgorzata Brauncajs, Anna Głobińska, Aleksandra Piechota-Polańczyk, Paweł Górski, Marek L. Kowalski
Other
News (s. 269)
Copyright© by Mediton. All rights reserved. No part of this publications may be reproduced or transmitted in any form or by any means now and hereafter known, electronic or printed without permission in writing from the Publisher.